On April 9, 2026, GSK plc purchased 330,000 ordinary shares at prices ranging from 2,124.00p to 2,158.00p, as part of an ongoing buyback program. This purchase increases the treasury shares held to 257,787,615 with a total of 4,058,396,834 ordinary shares in issue.